Articles

The company has diluted shareholders to the tune of roughly $12 billion via share sales in recent weeks to stock up on bitcoin.

Applying for retirement benefits can be confusing, and it’s all too easy to end up with permanent cuts to your benefits.

The two-year global tour concluded in Vancouver on Sunday.

Mangione, 26, was found with writings apparently critical of the health-insurance industry.

Financing is returning to commercial real estate ahead of 2025, yet mostly on temporary terms.

BofA sees the stock “priced to perfection,” while noting lesser visibility into tech deals and renewed attention on fair-value accounting.

AppLovin’s $135 billion market cap and 900% year-to-date surge through Friday’s close weren’t enough to earn it entry into the benchmark large-cap index.

BP has agreed to spin off its its offshore-wind into a newly formed joint venture with Japan’s JERA.

Super Micro’s stock rallies after Nasdaq extends the deadline for financial filings, but the stock is still being weighed down by an accounting overhang.

AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said it’s on track to seek approval for the drug from the Food and Drug Administration in 2025.

A pair of big-money acquisitions by advertising company Omnicom and insurance broker Arthur J. Gallagher tip the scales at a combined $27 billion.

A BofA analyst downgraded AMD’s stock, warning of limitations on the company’s ability to pick up share in an AI market dominated by Nvidia.